Intranodal Palisaded Myofibroblastoma Masquerading as N2 Non-Small Cell Lung Carcinoma Ivan H.W. Yim, BS, MBBS, Malcolm B. Will, PhD, FRCS, Catharine Dhaliwal, MBChB, PhD, Donald M. Salter, FRCPath, FRCP(Ed), William S. Walker, FRCS The Annals of Thoracic Surgery Volume 102, Issue 1, Pages e47-e48 (July 2016) DOI: 10.1016/j.athoracsur.2015.11.060 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig. 1 (A) Positron emission tomography (PET)/computed tomography scans showing (A) right paratracheal mass PET avid with standardized uptake value (SUV) 6.2 g/mL and (B) right upper lobe mass PET avid with SUV 2.7 g/mL. The Annals of Thoracic Surgery 2016 102, e47-e48DOI: (10.1016/j.athoracsur.2015.11.060) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Intraoperative image showing right-sided paratracheal mass. The Annals of Thoracic Surgery 2016 102, e47-e48DOI: (10.1016/j.athoracsur.2015.11.060) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Histologic section of intranodal palisaded myofibroblastoma. (Hematoxylin and eosin; ×20.) The Annals of Thoracic Surgery 2016 102, e47-e48DOI: (10.1016/j.athoracsur.2015.11.060) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions